These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12322708)

  • 1. Neutropenia associated with vincristine and L-asparaginase induction chemotherapy for canine lymphoma.
    Northrup NC; Rassnick KM; Snyder LA; Stone MS; Kristal O; Cotter SM; Moore AS
    J Vet Intern Med; 2002; 16(5):570-5. PubMed ID: 12322708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does L-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma?
    MacDonald VS; Thamm DH; Kurzman ID; Turek MM; Vail DM
    J Vet Intern Med; 2005; 19(5):732-6. PubMed ID: 16231719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
    Simon D; Nolte I; Eberle N; Abbrederis N; Killich M; Hirschberger J
    J Vet Intern Med; 2006; 20(4):948-54. PubMed ID: 16955821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vincristine-induced adverse events related to body weight in dogs treated for lymphoma.
    Sztukowski KE; Yaufman Z; Cook MR; Aarnes TK; Husbands BD
    J Vet Intern Med; 2024; 38(3):1686-1692. PubMed ID: 38563346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma.
    MacEwen EG; Rosenthal RC; Fox LE; Loar AS; Kurzman ID
    J Vet Intern Med; 1992; 6(4):230-4. PubMed ID: 1522554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma.
    Wang SL; Lee JJ; Liao AT
    Vet J; 2015 Jul; 205(1):69-73. PubMed ID: 26004824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asparaginase and MOPP treatment of dogs with lymphoma.
    Brodsky EM; Maudlin GN; Lachowicz JL; Post GS
    J Vet Intern Med; 2009; 23(3):578-84. PubMed ID: 19645842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs.
    Cawley JR; Wright ZM; Meleo K; Post GS; Clifford CA; Vickery KR; Vail DM; Bergman PJ; Thamm DH
    J Vet Intern Med; 2020 Mar; 34(2):882-889. PubMed ID: 32064697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity reactions associated with L-asparaginase administration in 142 dogs and 68 cats with lymphoid malignancies: 2007-2012.
    Blake MK; Carr BJ; Mauldin GE
    Can Vet J; 2016 Feb; 57(2):176-82. PubMed ID: 26834270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma.
    Jeffreys AB; Knapp DW; Carlton WW; Thomas RM; Bonney PL; Degortari A; Lucroy MD
    J Am Anim Hosp Assoc; 2005; 41(4):221-6. PubMed ID: 15995158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
    Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
    Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Tolerability of Combination Chemotherapy with Mitoxantrone and Dacarbazine in Dogs with Lymphoma.
    Intile JL; Rassnick KM; Al-Sarraf R; Chretin JD
    J Am Anim Hosp Assoc; 2019; 55(2):101-109. PubMed ID: 30653362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pretreatment Neutrophil Count on Chemotherapy Administration and Toxicity in Dogs with Lymphoma Treated with CHOP Chemotherapy.
    Fournier Q; Serra JC; Handel I; Lawrence J
    J Vet Intern Med; 2018 Jan; 32(1):384-393. PubMed ID: 29205493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study evaluating changes in pancreatic lipase immunoreactivity concentrations in canines treated with L-asparaginase (ASNase), vincristine, or both for lymphoma.
    Wright Z; Steiner J; Suchodolski J; Rogers K; Barton C; Brown M
    Can J Vet Res; 2009 Apr; 73(2):103-10. PubMed ID: 19436578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
    Zemann BI; Moore AS; Rand WM; Mason G; Ruslander DM; Frimberger AE; Wood CA; L'Heureux DA; Gliatto J; Cotter SM
    J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma ammonia concentration after L-asparaginase therapy in 27 dogs with high-grade lymphoma or leukemia.
    Speas AL; Lyles SE; Wirth KA; Fahey CE; Kow K; Lejeune AT; Milner RJ
    J Vet Emerg Crit Care (San Antonio); 2018 Mar; 28(2):130-139. PubMed ID: 29469204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and adverse events of L-Asparaginase administration as a first-line treatment for feline large-cell gastrointestinal lymphoma.
    Inazumi H; Toyoda H; Shimano S; Sakuma H; Sakamoto M; Nakagawa T; Fukuoka R; Ohmi A; Chambers JK; Uchida K; Goto-Koshino Y; Tomiyasu H
    J Vet Med Sci; 2024 Jul; 86(7):727-736. PubMed ID: 38825481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hyperammonemia after L-asparaginase administration in a dog.
    Lyles SE; Kow K; Milner RJ; Buckley GJ; Bandt C; Baxter KJ
    J Vet Emerg Crit Care (San Antonio); 2011 Dec; 21(6):673-8. PubMed ID: 22316261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.